ArticleScience advances2023

Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers.

Devivasha Bordoloi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.